“We’re too early for patents.”
I hear that a lot from biotech startups. And I get it, no product yet, no revenue, no legal team. Just a small enthusiastic group with big ideas.
But here’s the thing: at that stage, your intellectual property (IP) is often the only thing you do have. Your know-how, your data, your early invention: those are your assets. And investors know it.
They don’t expect a wall full of granted patents. But they do expect you to have thought about it. What’s protected and why? What’s kept as a trade secret? What could be licensed, or eventually sold?
A IP strategy doesn’t have to be big or expensive. It just has to be smart. One solid patent application shows you’re serious and give your idea real weight in due diligence, licensing talks or future funding rounds.
So don’t wait. Sit down with a patent attorney early and shape the strategy that fits your startup. We’re always up for a conversation.
Your future self, and your future investors, will thank you.